153 related articles for article (PubMed ID: 7842402)
1. Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms.
Zhu GG; Risteli L; Mäkinen M; Risteli J; Kauppila A; Stenbäck F
Cancer; 1995 Feb; 75(4):1010-7. PubMed ID: 7842402
[TBL] [Abstract][Full Text] [Related]
2. Organization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study.
Zhu GG; Stenbäck F; Risteli L; Risteli J; Kauppila A
Cancer; 1993 Sep; 72(5):1679-84. PubMed ID: 8348501
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer.
Santala M; Risteli J; Risteli L; Puistola U; Kacinski BM; Stanley ER; Kauppila A
Br J Cancer; 1998 Jun; 77(11):1825-31. PubMed ID: 9667653
[TBL] [Abstract][Full Text] [Related]
4. Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.
Santala M; Simojoki M; Risteli J; Risteli L; Kauppila A
Clin Cancer Res; 1999 Dec; 5(12):4091-6. PubMed ID: 10632345
[TBL] [Abstract][Full Text] [Related]
5. Expression of mRNAs for type I and type III procollagens in serous ovarian cystadenomas and cystadenocarcinomas.
Kauppila S; Saarela J; Stenbäck F; Risteli J; Kauppila A; Risteli L
Am J Pathol; 1996 Feb; 148(2):539-48. PubMed ID: 8579116
[TBL] [Abstract][Full Text] [Related]
6. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
[TBL] [Abstract][Full Text] [Related]
7. Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivo.
Kauppila S; Bode MK; Stenbäck F; Risteli L; Risteli J
Br J Cancer; 1999 Oct; 81(4):654-61. PubMed ID: 10574251
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
Devaney K; Goodman ZD; Ishak KG
Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum ICTP concentrations reflect poor prognosis in patients with ovarian carcinoma.
Santala M; Risteli L; Puistola U; Risteli J; Kauppila A
Ann Med; 1995 Feb; 27(1):57-61. PubMed ID: 7742000
[TBL] [Abstract][Full Text] [Related]
10. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
11. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer.
Tanos V; Prus D; Ayesh S; Weinstein D; Tykocinski ML; De-Groot N; Hochberg A; Ariel I
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):7-11. PubMed ID: 10428315
[TBL] [Abstract][Full Text] [Related]
12. 'Ovarian-type' stroma of pancreatic mucinous cystic tumor expresses smooth muscle phenotype.
Fukushima N; Mukai K
Pathol Int; 1997 Nov; 47(11):806-8. PubMed ID: 9413043
[TBL] [Abstract][Full Text] [Related]
13. Basement membrane status in undifferentiated carcinomas of the ovary. Immunohistochemical distribution of type IV collagen and laminin.
Kuwashima Y; Uehara T; Kurosumi M; Kishi K; Shiromizu K; Matsuzawa M; Takayama S
Eur J Gynaecol Oncol; 1995; 16(3):181-6. PubMed ID: 7664763
[TBL] [Abstract][Full Text] [Related]
14. Proliferative serous tumors of the ovary. Histologic features and prognosis.
Katzenstein AL; Mazur MT; Morgan TE; Kao MS
Am J Surg Pathol; 1978 Dec; 2(4):339-55. PubMed ID: 736209
[TBL] [Abstract][Full Text] [Related]
15. Periodic acid-Schiff stain as a prognostic indicator in serous and mucinous ovarian tumors.
Aalto ML; Collan Y
Int J Gynaecol Obstet; 1986 Feb; 24(1):27-34. PubMed ID: 2874066
[TBL] [Abstract][Full Text] [Related]
16. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
Kobayashi Y; Ochi M; Tokue A
Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of c-myc oncoprotein in mucinous and serous adenocarcinomas of the ovary.
Sasano H; Nagura H; Silverberg SG
Hum Pathol; 1992 May; 23(5):491-5. PubMed ID: 1314775
[TBL] [Abstract][Full Text] [Related]
18. Type I collagen metabolites as tumor markers in patients with lung carcinoma.
Kobayashi T; Gabazza EC; Taguchi O; Risteli J; Risteli L; Kobayashi H; Yasui H; Yuda H; Sakai T; Kaneda M; Adachi Y
Cancer; 1999 May; 85(9):1951-7. PubMed ID: 10223235
[TBL] [Abstract][Full Text] [Related]
19. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
[TBL] [Abstract][Full Text] [Related]
20. [Mucin histochemical and immunohistochemical studies of mucinous ovarian tumors].
Shi ZL
Zhonghua Bing Li Xue Za Zhi; 1989 Sep; 18(3):201-3. PubMed ID: 2636063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
